Loxo Oncology (LOXO) Tops Q1 EPS by 15c

Loxo Oncology (NASDAQ: LOXO) reported Q1 EPS of ($0.35), $0.15 better than the analyst estimate of ($0.50).

For earnings history and earnings-related data on Loxo Oncology (LOXO) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Beike (BEKE) PT Raised to $23 at Morgan Stanley
• Arena Group to rename as Paradium.AI, ticker changing to PAAI